Analysis of T cell responses against hepatitis C virus genotype 4 in Egypt

Journal of Hepatology

Volumn 40, Issue 2, 2004, Pages 313-318

  Elrefaei, Mohamed ^a   El sheikh, Nabila ^b   Kamal, Karim ^c   Cao, Huyen ^a  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^b AL AZHAR UNIVERSITY   (Egypt)

^c US Naval Medical Research Unit No 3 Egypt   (Egypt)

Author keywords

CD4; CD8; Hepatitis C virus; Immunity; Schistosoma mansoni

Indexed keywords

ADULT; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; EGYPT; EVALUATION; FEMALE; GENE IDENTIFICATION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; T LYMPHOCYTE;

EID: 1642450655     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2003.10.007     Document Type: Article

References (36)

1. Lauer G.M., Walker B.D. Hepatitis C virus infection. N Engl J Med. 345:2001;41-52.
2. Cohen J. The scientific challenge of hepatitis C. Science. 285:1999;26-30.
3. Cooper S., Erickson A.L., Adams E.J., Kansopon J., Weiner A.J., Chien D.Y., et al. Analysis of a successful immune response against hepatitis C virus. Immunity. 10:1999;439-449.
4. Lechner F., Wong D.K., Dunbar P.R., Chapman R., Chung R.T., Dohrenwend P.B., et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med. 191:2000;1499-1512.
5. Takaki A., Wiese M., Maertens G., Depla E., Seifert U., Leibetrau A., et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med. 6:2000;578-582.
6. Gerlach J.T., Diepolder H.M., Jung M.C., Gruener N., Schraut W., Zachoval R., et al. Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis C. Gastroenterology. 117:1999;933-941.
7. Chang K.M., Thimme R., Melpoder J.J., Oldach D., Pemberon J., Moorhead-Loudis J., et al. Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection. Hepatology. 33:2001;267-276.
8. Koziel M., Dudley D., Afdhl N., Grakoui A., Rice C., Choo Q., et al. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest. 96:1995;2311-2321.
9. Koziel M.J., Dudley D., Afdhal N., Choo Q.L., Houghton M., Ralston R., et al. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol. 67:1993;7522-7532.
10. Battegay M., Fikes J., Di Bisceglie A.M., Wentworth P.A., Sette A., Celis E., et al. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus encoded peptides binding to HLA-A2.1 molecules. J Virol. 69:1995;2452-2470.
11. Cerny A., McHutchinson J., Pasquinelli C., Brown M.E., Brothers M.A., Grabscheid B., et al. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA-A2 binding motifs. J Clin Invest. 95:1995;521-530.
12. Kita H., Moriyama T., Kaneko T., Okamoto H., Hiroishi K., Ohnishi S., et al. HLA B44-restricted cytotoxic T lymphocyte responses to the peptides of HCV nucleoprotein residues 81-100 in patients with chronic hepatitis C. J Gastroenterol. 30:1995;809-812.
13. Missale G., Bertoni R., Lamonaca V., Valli A., Massari M., Mori C., et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest. 98:1996;706-714.
14. Zein N.N. Clinical significance of hepatitis C genotypes. Clin Microbiol Rev. 13:2000;223-235.
15. Farci P., Purcell R.H. Clinical significance of hepatitis C virus genotypes and quasispecies. Semin Liver Dis. 20:2000;103-126.
16. Strickland T.G., Elhefni H., Salman T., Waked I., Abdel-Hamid M., Mikhail N., et al. Role of hepatitis C infection in chronic liver disease in Egypt. Am J Trop Med Hyg. 67:2002;436-442.
17. Heintges T., Wands J. Hepatitis C virus: epidemiology and transmission. Hepatology. 26:1997;521-526.
18. Kamel M.A., Gaffar Y.A., Wasef M.A., Wright M., Clark L.C., DeWolf Miller F. High HCV prevalence in Egyptian blood donors. Lancet. 340:1992;427-429.
19. Frank C., Mostafa M., Strickland G.T., Lavanchy D., Arthur R., Madgder L., et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 355:2000;887-891.
20. Kamal S., Madwar M., Bianchi L., Tawil A., Fawzy R., Peter T., et al. Clinical, virological and histological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni. Liver. 20:2000;281-289.
21. Halim A.-B., Garry R.F., Srikanta D., Berber M.A. Effect of schistosomiasis and hepatitis on liver disease. Am J Trop Med Hyg. 60:1999;915-920.
22. Blanton R.E., Salam S.E., Kariuki H.C., Magak P., Silva L.K., Muchiri E.M., et al. Population-based differences in Schistosoma mansoni-and hepatitis C-induced disease. J Infect Dis. 185:2002;1644-1649.
23. Kamel M.A., Miller J., el Masry A.G., Zakaria S., Khattab M., Essmat G., et al. The epidemiology of Schistosoma mansoni, hepatitis B and hepatitis C infection in Egypt. Ann Trop Med Parasitol. 88:1994;501-509.
24. Angelico M., Renganathan E., Gandin C., Fathy M., Profili M.C., Refai W., et al. Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infection. J Hepatol. 26:1997;236-243.
25. Hofgartner W.T., Kant J.A., Weck E.K. Hepatitis C virus quantitation: optimization of strategies for detecting low-level viremia. J Clin Microbiol. 38:2000;888-891.
26. Boctor F.N., Shaheen H.I. Immunoaffinity fractionation of Schistosoma mansoni worm antigens using human antibodies and its application for serodiagnosis. Immunology. 57:1986;587-593.
27. Chamberlain R.W., Adams N., Saeed A.A., Simmonds P., Elliott R.M. Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the middle east. J Gen Virol. 78:1997;1341-1347.
28. Neville A., Prescott L.E.B. V, Adams N., Pike I., Rodgers B., El-zayadi A., et al. Antigenic variation of Core, NS3 and NS5 proteins among genotypes of hepatitis C virus. J Clin Microbiol. 35:1997;3062-3070.
29. Simmond P., Holmes E.C., Cha T.A., Chan S.W., McOmish F., Irvine B., et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol. 74:1993;2391-2399.
30. Ward S., Lauer G.M., Isba R., Walker B.D., Klenerman P. Cellular immune responses against hepatitis c virus: the evidence base 2002. Clin Exp Immunol. 128:2002;195-203.
31. Kamal S., Bianchi L., Al Tawil A., Koziel M., El Sayed Khalifa K., Peter T., et al. Specific cellular immune response and cytokine patterns in patients coinfected with hepatitis C virus and Schistosoma mansoni. J Infect Dis. 184:2001;972-992.
32. Godkin A., Jeanguet N., Thursz M., Openshaw P., Thomas H. Characterization of novel HLA-DR11-restricted HCV epitopes reveal both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients. Eur J Immunol. 31:2001;1438-1446.
33. Wawrzynowicz-Syczweska M., Underhill J.A., Clare M.A., Boron-Kaczmarska A., McFarlance I.G., Donaldson P.T. HLA class II genotypes associated with chronic hepatitis C virus infection and response to alpha-interferon treatment in Poland. Liver. 20:2000;234-239.
34. Alrich L., Fort M., Izopet J., Vinel J.P., Charlet J.P., Selves J., et al. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology. 113:1997;1675-1681.
35. Gad M., Tanaka E., Orii K., Rokuhara A., Nooman Z., Serwah A.H., et al. Relationship between hepatitis C virus infection and schistosomal liver disease: not simply an additive effect. J Gastroenterol. 36:2001;753-758.
36. Kamal S., Rasenack J., Bianchi L., Al Tawil A., El Sayed Khalifa K., Peters T., et al. Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response. Gastroenterology. 121:2001;646-656.